These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1154343)

  • 21. [Evaluation of various hemorheologic parameters in diabetes mellitus].
    Cella A; Bianchi E; Reali GL; Piana A; Armani U
    Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fibrinogen and diabetic microangiopathy].
    Mojto V
    Vnitr Lek; 1997 Feb; 43(2):81-6. PubMed ID: 9245073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemorheologic findings in diabetes and their clinical relevance].
    Volger E
    Wien Med Wochenschr; 1986; 136 Spec No():5-10. PubMed ID: 3825172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood viscosity in young male diabetics with and without retinopathy.
    Lowe GD; Lowe JM; Drummond MM; Reith S; Belch JJ; Kesson CM; Wylie A; Foulds WS; Forbes CD; MacCuish AC; Manderson WG
    Diabetologia; 1980 May; 18(5):359-63. PubMed ID: 7429058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alpha 2-antiplasmin in diabetes mellitus and its relation to diabetic retinopathy].
    Sánchez Martín S; García Díez LC; García Marcos MA; Miralles García JM
    Rev Clin Esp; 1983 May; 169(3):189-90. PubMed ID: 6612032
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of blood clotting and fibrinolytic disorders in diabetics in the development of pathological changes in blood vessels].
    Chmielewski J
    Wiad Lek; 1973 Apr; 26(7):615-7. PubMed ID: 4573502
    [No Abstract]   [Full Text] [Related]  

  • 27. Correlation between macrovascular disease as assessed by bioimpedance plethysmography and various parameters used to assess diabetic "control".
    Elias AN; Domurat ES; Friis R; Valenta LJ
    J Natl Med Assoc; 1989 Apr; 81(4):357-62. PubMed ID: 2738945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of lipid metabolism in diabetics with retinal angiopathies following the administration of triiodothyronine].
    Prokop V; Musil F; Musilová Z; Tvrzký J; Kozina M
    Cas Lek Cesk; 1970 Aug; 109(34):798-800. PubMed ID: 5455599
    [No Abstract]   [Full Text] [Related]  

  • 29. Fibrinolysis and diabetic retinopathy.
    Almér LA; Pandolfi M
    Diabetes; 1976; 25(2 SUPPL):807-10. PubMed ID: 61139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinolytic activity, autonomic neuropathy, and circulation in diabetes mellitus.
    Almér LO; Sundkvist G; Lilja B
    Diabetes; 1983 May; 32 Suppl 2():4-7. PubMed ID: 6600036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of serum lipids and chylomicrons in diabetic patients with peripheral arterial circulatory disorders].
    Jähnigen B; Ziegler A; Heller H
    Z Gesamte Inn Med; 1970 Jun; 25(12):550-4. PubMed ID: 5523401
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood viscosity and erythrocyte deformability in diabetic retinopathy].
    Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M
    Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinolytic enhancement in diabetic microangiopathy with defibrotide.
    Belcaro G; Marelli C; Pomante P; Laurora G; Cesarone MR; Ricci A; Girardello R; Barsotti A
    Angiology; 1992 Oct; 43(10):793-800. PubMed ID: 1476266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological fibrinolysis in diabetes mellitus.
    Chakrabarti R; Fearnley GR
    Diabetologia; 1974 Feb; 10(1):19-22. PubMed ID: 4835611
    [No Abstract]   [Full Text] [Related]  

  • 35. [Alpha2-macroglobulin concentration in the serum in chronic pancreatitis, liver cirrhosis and diabetes mellitus].
    Geller LI; Kazimirchik AP; Kozlova ZP
    Vopr Med Khim; 1973; 19(1):96-9. PubMed ID: 4788012
    [No Abstract]   [Full Text] [Related]  

  • 36. Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes.
    Jones RL
    Diabetes; 1985 Sep; 34(9):836-43. PubMed ID: 4029510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
    Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
    Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal endothelial release of fibrinolytic activity and fibronectin in diabetic microangiopathy.
    Haitas B; Barnes AJ; Cederholm-Williams SA; Moore J; Shogry ME; Turner RC
    Diabetologia; 1984 Nov; 27(5):493-6. PubMed ID: 6510595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Some indices of the blood coagulation system and thrombus-formation in patients with diabetes mellitus].
    Ivanova NA
    Kardiologiia; 1971 Aug; 11(8):121-5. PubMed ID: 5160867
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fibrinolysis and vascular diseases].
    Udvardy M; Boda Z
    Orv Hetil; 1996 Aug; 137(34):1851-5. PubMed ID: 8927337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.